[CytoReason in The Times of Israel] Sanofi extends cooperation with Israel’s CytoReason for bowel disease drug discovery

Tel Aviv-based startup that uses AI to build digital models of the human immune system and diseases inks multi-million-dollar deal with French drugmaker

Read more here.